Viremic control and viral coreceptor usage in two HIV-1-infected persons homozygous for CCR5 Δ32. (15th May 2015)

• Record Type: Journal Article
• Authors: Henrich, Timothy J.; Hanhauser, Emily; Hu, Zixin; Stellbrink, Hans-Jürgen; Noah, Christian; Martin, Jeffrey N.; Deeks, Steven G.; Kuritzkes, Daniel R.; Pereyra, Florencia
• Is Part Of: AIDS. Volume 29:Number 8(2015)
• Publication Date: 2015-05-15
• Subjects: AIDS (Disease) -- Periodicals; Acquired Immunodeficiency Syndrome; AIDS (Disease); Periodicals; Periodicals; 616.9792005
• DOI: 10.1097/QAD.0000000000000629
• Languages: English
• ISSNs: 0269-9370

Abstract

<abstract> <title> <x xml:space="preserve">Abstract</x> </title> <sec> <title>Objectives:</title> <p>To determine viral and immune factors involved in transmission and control of HIV-1 infection in persons without functional CCR5.</p> </sec> <sec> <title>Design:</title> <p>Understanding transmission and control of HIV-1 in persons homozygous for <italic>CCR5</italic><sup><italic>Δ32</italic></sup> is important given efforts to develop HIV-1 curative therapies aimed at modifying or disrupting CCR5 expression.</p> </sec> <sec> <title>Methods:</title> <p>We identified two HIV-infected <italic>CCR5</italic><sup><italic>Δ32/Δ32</italic></sup> individuals among a cohort of patients with spontaneous control of HIV-1 infection without antiretroviral therapy and determined coreceptor usage of the infecting viruses. We assessed genetic evolution of full-length HIV-1 envelope sequences by single-genome analysis from one participant and his sexual partner, and explored HIV-1 immune responses and HIV-1 mutations following virologic escape and disease progression.</p> </sec> <sec> <title>Results:</title> <p>Both participants experienced viremia of less than 4000 RNA copies/ml with preserved CD4<sup>+</sup> T-cell counts off antiretroviral therapy for at least 3.3 and 4.6 years after diagnosis, respectively. One participant had phenotypic evidence of X4 virus, had no known favorable human leukocyte antigen alleles, and appeared to be infected by minority X4 virus from a pool that predominately used CCR5 for entry. The second participant had virus that was unable to use CXCR4 for entry in phenotypic assay but was able to engage alternative viral coreceptors (e.g., CXCR6) <italic>in vitro</italic>.</p> </sec> <sec> <title>Conclusion:</title> <p>Our study demonstrates that individuals may be infected by minority X4 viruses from a population that predominately uses CCR5 for entry, and that viruses may bypass traditional HIV-1 coreceptors (CCR5 and CXCR4) completely by engaging alternative coreceptors to establish and propagate HIV-1 infection.</p> </sec> </abstract>